The European Parliament’s Public Health (SANT) Committee adopted two oral questions on Thursday (15 October), calling on both the European Commission and the Council of the European Union to address the impact of US pharmaceutical pricing policies on access to medicines in Europe.
Led by Danish Renew Europe MEP